Click for best price
Nucleic Acid Drugs Market Size, Share 2023
This report contains market size and forecasts of Nucleic Acid Drugs in Global, including the following market information:
Global Nucleic Acid Drugs Market Size 2024-2032, ($ millions)
The global Nucleic Acid Drugs market is projected to reach US$ million by 2032.
We surveyed the Nucleic Acid Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nucleic Acid Drugs Market, by Type, 2024-2032 ($ millions)
Global Nucleic Acid Drugs Market Segment Percentages, by Type
Antisense Nucleic Acid Drugs
siRNA Drugs
saRNA Drugs
miRNA Drugs
mRNA Drugs
other
Global Nucleic Acid Drugs Market, by Application, 2024-2032 ($ millions)
Global Nucleic Acid Drugs Market Segment Percentages, by Application
Genetic Disease
Cancer
Cardiovascular Diseases
Other
Global Nucleic Acid Drugs Market, By Region and Country, 2024-2032 ($ Millions)
Global Nucleic Acid Drugs Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Mina Therapeutics
BioNTech
NeXstar Pharmaceuticals
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Miragen Therapeutics
| Report Attributes |
Report Details |
| Report Title |
Nucleic Acid Drugs Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nucleic Acid Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nucleic Acid Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nucleic Acid Drugs Overall Market Size
2.1 Global Nucleic Acid Drugs Market Size: 2023 VS 2032
2.2 Global Nucleic Acid Drugs Market Size, Prospects & Forecasts: 2023-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Nucleic Acid Drugs Players in Global Market
3.2 Global Companies Nucleic Acid Drugs Product & Technology
4 Nucleic Acid Drugs Companies Profiles
4.1 Sarepta Therapeutics
4.1.1 Sarepta Therapeutics Company Summary
4.1.2 Sarepta Therapeutics Business Overview
4.1.3 Sarepta Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.1.4 Sarepta Therapeutics Nucleic Acid Drugs R&D, and Plans
4.2 Ionis Pharmaceuticals
4.2.1 Ionis Pharmaceuticals Company Summary
4.2.2 Ionis Pharmaceuticals Business Overview
4.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Product Offerings & Technology
4.2.4 Ionis Pharmaceuticals Nucleic Acid Drugs R&D, and Plans
4.3 Alnylam
4.3.1 Alnylam Company Summary
4.3.2 Alnylam Business Overview
4.3.3 Alnylam Nucleic Acid Drugs Product Offerings & Technology
4.3.4 Alnylam Nucleic Acid Drugs R&D, and Plans
4.4 Mina Therapeutics
4.4.1 Mina Therapeutics Company Summary
4.4.2 Mina Therapeutics Business Overview
4.4.3 Mina Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.4.4 Mina Therapeutics Nucleic Acid Drugs R&D, and Plans
4.5 BioNTech
4.5.1 BioNTech Company Summary
4.5.2 BioNTech Business Overview
4.5.3 BioNTech Nucleic Acid Drugs Product Offerings & Technology
4.5.4 BioNTech Nucleic Acid Drugs R&D, and Plans
4.6 NeXstar Pharmaceuticals
4.6.1 NeXstar Pharmaceuticals Company Summary
4.6.2 NeXstar Pharmaceuticals Business Overview
4.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Product Offerings & Technology
4.6.4 NeXstar Pharmaceuticals Nucleic Acid Drugs R&D, and Plans
4.7 Nippon Shinyaku
4.7.1 Nippon Shinyaku Company Summary
4.7.2 Nippon Shinyaku Business Overview
4.7.3 Nippon Shinyaku Nucleic Acid Drugs Product Offerings & Technology
4.7.4 Nippon Shinyaku Nucleic Acid Drugs R&D, and Plans
4.8 Moderna Therapeutics
4.8.1 Moderna Therapeutics Company Summary
4.8.2 Moderna Therapeutics Business Overview
4.8.3 Moderna Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.8.4 Moderna Therapeutics Nucleic Acid Drugs R&D, and Plans
4.9 CureVac
4.9.1 CureVac Company Summary
4.9.2 CureVac Business Overview
4.9.3 CureVac Nucleic Acid Drugs Product Offerings & Technology
4.9.4 CureVac Nucleic Acid Drugs R&D, and Plans
4.10 Regulus Therapeutics
4.10.1 Regulus Therapeutics Company Summary
4.10.2 Regulus Therapeutics Business Overview
4.10.3 Regulus Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.10.4 Regulus Therapeutics Nucleic Acid Drugs R&D, and Plans
4.11 Miragen Therapeutics
4.11.1 Miragen Therapeutics Company Summary
4.11.2 Miragen Therapeutics Business Overview
4.11.3 Miragen Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.11.4 Miragen Therapeutics Nucleic Acid Drugs R&D, and Plans
5 Sights by Region
5.1 By Region - Global Nucleic Acid Drugs Market Size, 2024 & 2032
5.2 By Region - Global Nucleic Acid Drugs Revenue, (2024-2032)
5.3 United States
5.3.1 Key Players of Nucleic Acid Drugs in United States
5.3.2 United States Nucleic Acid Drugs Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Nucleic Acid Drugs in Europe
5.4.2 Europe Nucleic Acid Drugs Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Nucleic Acid Drugs in China
5.5.2 China Nucleic Acid Drugs Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Nucleic Acid Drugs Market Size Markets, 2024 & 2032
6.2 Antisense Nucleic Acid Drugs
6.3 siRNA Drugs
6.4 saRNA Drugs
6.5 miRNA Drugs
6.6 mRNA Drugs
6.7 other
7 Sights by Application
7.1 By Application - Global Nucleic Acid Drugs Market Size, 2024 & 2032
7.2 Genetic Disease
7.3 Cancer
7.4 Cardiovascular Diseases
7.5 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nucleic Acid Drugs Market Opportunities & Trends in Global Market
Table 2. Nucleic Acid Drugs Market Drivers in Global Market
Table 3. Nucleic Acid Drugs Market Restraints in Global Market
Table 4. Key Players of Nucleic Acid Drugs in Global Market
Table 5. Global Companies Nucleic Acid Drugs Product & Technology
Table 6. Sarepta Therapeutics Company Summary
Table 7. Sarepta Therapeutics Nucleic Acid Drugs Product Offerings
Table 8. Ionis Pharmaceuticals Company Summary
Table 9. Ionis Pharmaceuticals Nucleic Acid Drugs Product Offerings
Table 10. Alnylam Company Summary
Table 11. Alnylam Nucleic Acid Drugs Product Offerings
Table 12. Mina Therapeutics Company Summary
Table 13. Mina Therapeutics Nucleic Acid Drugs Product Offerings
Table 14. BioNTech Company Summary
Table 15. BioNTech Nucleic Acid Drugs Product Offerings
Table 16. NeXstar Pharmaceuticals Company Summary
Table 17. NeXstar Pharmaceuticals Nucleic Acid Drugs Product Offerings
Table 18. Nippon Shinyaku Company Summary
Table 19. Nippon Shinyaku Nucleic Acid Drugs Product Offerings
Table 20. Moderna Therapeutics Company Summary
Table 21. Moderna Therapeutics Nucleic Acid Drugs Product Offerings
Table 22. CureVac Company Summary
Table 23. CureVac Nucleic Acid Drugs Product Offerings
Table 24. Regulus Therapeutics Company Summary
Table 25. Regulus Therapeutics Nucleic Acid Drugs Product Offerings
Table 26. Miragen Therapeutics Company Summary
Table 27. Miragen Therapeutics Nucleic Acid Drugs Product Offerings
Table 28. By Region? Global Nucleic Acid Drugs Revenue, (US$, Mn), 2024 & 2032
Table 29. By Region - Global Nucleic Acid Drugs Revenue, (US$, Mn), 2024-2032
Table 30. By Type ? Global Nucleic Acid Drugs Market Size, (US$, Mn), 2024 & 2032
Table 31. By Application? Global Nucleic Acid Drugs Market Size, (US$, Mn), 2024 & 2032
List of Figures
Figure 1. Nucleic Acid Drugs Segment by Type in 2032
Figure 2. Nucleic Acid Drugs Segment by Application in 2032
Figure 3. Global Nucleic Acid Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nucleic Acid Drugs Market Size: 2023 VS 2032 (US$, Mn)
Figure 6. Global Nucleic Acid Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global Nucleic Acid Drugs Revenue Market Share, 2024-2032
Figure 8. By Type - Global Nucleic Acid Drugs Revenue Market Share, 2024-2032
Figure 9. By Application - Global Nucleic Acid Drugs Revenue Market Share, 2024-2032
